You have 9 free searches left this month | for more free features.

Lymphoma

Showing 1 - 25 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, T-Cell, Cutaneous, Hodgkin Disease, Lymphoma, T-Cell, Peripheral Trial (SGN-35T)

Not yet recruiting
  • Lymphoma, T-Cell, Cutaneous
  • +5 more
  • (no location specified)
Nov 2, 2023

Follicular Lymphoma, Marginal Zone Lymphoma, Indolent Non-hodgkin Lymphoma Trial in Boston (Obinutuzumab, Glofitamab)

Not yet recruiting
  • Follicular Lymphoma
  • +2 more
  • Boston, Massachusetts
    Dana-Farber Cancer Institute
Mar 13, 2023

Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma Trial in Boston (CD79b-19 CAR T cells,

Not yet recruiting
  • Non-hodgkin Lymphoma
  • +9 more
  • CD79b-19 CAR T cells
  • +2 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 6, 2023

(CHANT)Real World Study of Duvelisib in Treatment of

Not yet recruiting
  • Follicular Lymphoma
  • +5 more
  • (no location specified)
Jun 20, 2023

Relapsed or Refractory B-cell Lymphoma, Diffuse Large B-cell Lymphoma (DLBCL), Follicular Lymphoma (FL) Trial in Beijing

Recruiting
  • Relapsed or Refractory B-cell Lymphoma
  • +6 more
  • Beijing, China
    Beijing Cancer Hospital
Feb 6, 2023

Relapsed Non-Hodgkin Lymphoma, Refractory Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial (BGB-21447)

Not yet recruiting
  • Relapsed Non-Hodgkin Lymphoma
  • +6 more
  • (no location specified)
Apr 12, 2023

Follicular Lymphoma, B-Cell Lymphoma, Mantle Cell Lymphoma Trial in New York (Tazemetostat Pill)

Not yet recruiting
  • Follicular Lymphoma
  • +3 more
  • Tazemetostat Pill
  • New York, New York
    Weill Cornell Medicine/NewYork-Presbyterian Hospital
Jun 28, 2023

Communication Training Intervention for Large B-Cell Lymphoma

Recruiting
  • Lymphoma, B-Cell
  • +5 more
  • Hematolo-GIST Training
  • Participants Appointment
  • New York, New York
  • +2 more
Jul 3, 2023

Diffuse Large B Cell Lymphoma, Transformed Indolent Non-Hodgkin's Lymphoma, Follicular Lymphoma Trial (FT596, Cyclophosphamide,

Withdrawn
  • Diffuse Large B Cell Lymphoma
  • +4 more
  • (no location specified)
Jun 28, 2023

Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

Active, not recruiting
  • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
  • +22 more
  • External Beam Radiation Therapy
  • Orbital Radiation
  • Houston, Texas
    M D Anderson Cancer Center
Dec 9, 2022

Patients Undergoing Follicular Lymphoma Clinical Research

Not yet recruiting
  • Follicular Lymphoma
    • San Francisco, California
      Power Life Sciences
    Sep 15, 2023

    Elastography and Treatment of Lymphoma

    Not yet recruiting
    • Elastography
    • Lymphoma
      • (no location specified)
      Jul 23, 2023

      Classical Hodgkin Lymphoma, Non-Hodgkin Lymphoma Trial (GEN3017)

      Not yet recruiting
      • Classical Hodgkin Lymphoma
      • Non-Hodgkin Lymphoma
      • GEN3017
      • (no location specified)
      Aug 25, 2023

      High-Dose Methotrexate Clearance in Diffuse Large B-Cell

      Recruiting
      • Central Nervous System Lymphoma
      • Diffuse Large B-Cell Lymphoma
      • Non-Interventional Study
      • Columbus, Ohio
        Ohio State University Comprehensive Cancer Center
      Sep 8, 2023

      Lymphoma, B-Cell, Relapsed Cancer, Refractory Lymphoma Trial in Boston (Adaptive Bridging Radiation Therapy (ABRT))

      Not yet recruiting
      • Lymphoma, B-Cell
      • +7 more
      • Adaptive Bridging Radiation Therapy (ABRT)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Aug 16, 2023

      DLBCL - Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial in Xiamen (Lenalidomide combined with G-CHOP (LO CHOP))

      Recruiting
      • DLBCL - Diffuse Large B Cell Lymphoma
      • Follicular Lymphoma
      • Lenalidomide combined with G-CHOP (LO CHOP)
      • Xiamen, Fujian, China
        Bing Xu
      Nov 28, 2023

      B-Cell Non-Hodgkin Lymphoma, DLBCL, Not Otherwise Specified, High Grade B-Cell Lymphoma Trial in Seattle (Acalabrutinib,

      Recruiting
      • B-Cell Non-Hodgkin Lymphoma
      • +7 more
      • Seattle, Washington
        Fred Hutch/University of Washington Cancer Consortium
      Dec 9, 2022

      Primary CNS Lymphoma and Primary Vitreoretinal Lymphoma Trial (intensity-modulated radiotherapy (IMRT))

      Not yet recruiting
      • Primary Central Nervous System Lymphoma and Primary Vitreoretinal Lymphoma
      • intensity-modulated radiotherapy (IMRT)
      • (no location specified)
      Jun 4, 2023

      Living Conditions of Diffuse Large B-Cell Lymphoma or Follicular

      Completed
      • Diffuse Large Cell Diffuse Lymphoma
      • Follicular Lymphoma
      • Questionnaires
      • Collection of clinical data and treatments
      • Dijon, France
        Chu Dijon Bourogne
      Jan 31, 2023

      Follicular Lymphoma Trial in New York (Mosunetuzumab, Tazemetostat Pill)

      Not yet recruiting
      • Follicular Lymphoma
      • New York, New York
        Weill Cornell Medicine/NewYork-Presbyterian Hospital
      Aug 8, 2023

      Primary Ocular Adnexal MALT Lymphoma Trial (Rituximab, Involved Site Radiation Therapy)

      Not yet recruiting
      • Primary Ocular Adnexal MALT Lymphoma
      • (no location specified)
      Sep 26, 2023

      Burkitt Lymphoma, Lymphoblastic Lymphoma, Adult, Acute Lymphoblastic Leukemia, Adult Trial in Zhuhai (Thiotepa,

      Recruiting
      • Burkitt Lymphoma
      • +2 more
      • Thiotepa, cyclophosphamide, cladribine, and cytarabine conditioning regimen
      • Zhuhai, Guangdong, China
        The Fifth Affiliated Hospital of Sun Yat-sen University
      Sep 25, 2023

      Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma

      Not yet recruiting
      • Lymphoma, B-Cell
      • +6 more
      • Plasma metabolomic profile by Ultra-high performance liquid chromatography with quadrupole time-of-flight mass spectrometry (UPLC-QTOFMS)
      • Guayaquil, Guayas, Ecuador
        Instituto Oncol├│gico Nacional Dr. Juan Tanca Marengo
      Apr 27, 2023

      Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

      Not yet recruiting
      • Follicular Lymphoma
      • Low Grade Non-Hodgkin's Lymphoma, Adult
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 13, 2023

      Patient Perspectives in Mantle Cell Lymphoma Clinical Research

      Not yet recruiting
      • Mantle Cell Lymphoma
        • San Francisco, California
          Power Life Sciences
        Sep 15, 2023